SPROGOE KENNETT

PrivateCIK: 1965630
Location

HELLERUP, G7

SPROGOE KENNETT enters ASCENDIS PHARMA A/S with 19.57K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Indirect Derivatives
InsiderSPROGOE KENNETTCIK 1965630
IssuerASCENDIS PHARMA A/SCIK 1612042
Officer· See Remarks
Since Mar 2026
19.57K
Baseline shares
99% direct
19.46K
Direct ownership
1 position
131.57K
Derivative underlying
8 instruments
2
Security positions
110.00 indirect
Non-Derivative Holdings2

Ordinary Shares

Direct
Shares owned19.46K

Ordinary Shares

Indirect
Shares owned110.00
Total
19.46K direct·110.00 indirect19.57K
Derivative Holdings8

Restricted Stock Units

Direct
Underlying security
Ordinary Shares

Underlying shares

3.20K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Restricted Stock Units

Direct
Underlying security
Ordinary Shares

Underlying shares

4.25K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Restricted Stock Units

Direct
Underlying security
Ordinary Shares

Underlying shares

9.55K

Shares owned

N/A

Exercise price

Expiration

Exercise window

Warrants

Direct
Underlying security
Ordinary Shares

Underlying shares

14.50K

Shares owned

N/A

Exercise price

139.65

Expiration

Exercise window

Warrants

Direct
Underlying security
Ordinary Shares

Underlying shares

22.75K

Shares owned

N/A

Exercise price

176.28

Expiration

Exercise window

Warrants

Direct
Underlying security
Ordinary Shares

Underlying shares

5.31K

Shares owned

N/A

Exercise price

37.18

Expiration

Exercise window

Warrants

Direct
Underlying security
Ordinary Shares

Underlying shares

27K

Shares owned

N/A

Exercise price

108

Expiration

Exercise window

Warrants

Direct
Underlying security
Ordinary Shares

Underlying shares

45K

Shares owned

N/A

Exercise price

62.17

Expiration

Exercise window

Total

Underlying

131.57K

Owned

0.00

SPROGOE KENNETT — Initial Ownership Disclosure (Form 3) Filed Mar 18, 2026 | Finecho